(Q71585396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

A phase II trial of doxorubicin HCl Liposome Injection in patients with advanced pancreatic adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

main subject

phase II clinical trial

1 reference

pancreatic adenocarcinoma

inferred from title

1 reference

1 reference

G K Schwartz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

E S Casper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

77-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02614225

19 October 2019

exact match

0 references

cites work

Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice

1 reference

12 December 2020

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

12 December 2020

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

1 reference

12 December 2020

Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes

1 reference

12 December 2020

Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model

1 reference

12 December 2020

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study

1 reference

12 December 2020

Increased accumulation of drugs in multidrug-resistant cells induced by liposomes

1 reference

12 December 2020

Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

1 reference

12 December 2020

Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38

1 reference

12 December 2020

Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes

1 reference

12 December 2020

Liposomes as drug carriers in cancer therapy

1 reference

12 December 2020

Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin

1 reference

12 December 2020

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin

1 reference

12 December 2020

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

12 December 2020

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model

1 reference

12 December 2020

Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group report

1 reference

12 December 2020

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study

1 reference

12 December 2020

Cancer statistics, 1994.

1 reference

12 December 2020

5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas

1 reference

12 December 2020

Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).

1 reference

12 December 2020

Liposomes--problems and promise as selective drug carriers

1 reference

12 December 2020

Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).

1 reference

12 December 2020

Phase II study of epirubicin in advanced adenocarcinoma of the pancreas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02614225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7499113%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference